Published in Cancer on May 01, 1981
Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg (1991) 1.30
Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res (2008) 1.11
Localized operable soft tissue sarcoma of the upper extremity. Presentation, management, and factors affecting local recurrence in 108 patients. Ann Surg (1987) 1.04
Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer (1985) 0.91
Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation. Ann Surg Oncol (2007) 0.85
Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy. Sarcoma (1999) 0.85
The management of locally recurrent soft-tissue sarcoma. Ann Surg (1982) 0.83
Liposarcoma of the thyroid. Sarcoma (2004) 0.79
Low dose-rate interstitial brachytherapy in soft tissue sarcomas. Sarcoma (1999) 0.75
New advances in surgical oncology. West J Med (1983) 0.75
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am (1971) 9.93
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol (2007) 7.33
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. JAMA (1994) 4.01
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am (1998) 3.56
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res (2000) 3.39
Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect (1998) 3.27
A clinical and pathological staging system for soft tissue sarcomas. Cancer (1977) 3.19
Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys (1995) 3.05
Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am (1994) 2.93
The response of articular cartilage to mechanical injury. J Bone Joint Surg Am (1982) 2.92
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am (1994) 2.86
Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am (1999) 2.85
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am (1986) 2.49
A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg (1996) 2.49
The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am (1982) 2.46
Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery (1970) 2.34
Chondroblastoma of bone. J Bone Joint Surg Am (2000) 2.33
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol (1995) 2.33
Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am (1988) 2.24
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg Am (1970) 2.15
Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys (1990) 2.11
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res (1999) 2.10
Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor. J Bone Joint Surg Am (1990) 2.08
Radiation therapy in the treatment of aggressive fibromatoses (desmoid tumors). Cancer (1984) 1.94
Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect (1998) 1.90
Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg (1981) 1.86
Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol (1993) 1.84
Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res (2001) 1.83
Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature. J Urol (1981) 1.82
Fractures about the hip in an institutionalizedpatient population. II. Survival and ability to walk again. J Bone Joint Surg Am (1968) 1.82
Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst (1993) 1.76
Calcific myonecrosis. A late sequela to compartment syndrome of the leg. Clin Orthop Relat Res (1995) 1.75
Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer (1975) 1.73
Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys (1995) 1.73
Articular cartilage repair and transplantation. Arthritis Rheum (1998) 1.73
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Massive resection and allograft transplantation in the treatment of malignant bone tumors. N Engl J Med (1976) 1.67
Desmoplastic fibroma of bone. A report of eight cases and review of the literature. J Bone Joint Surg Am (1985) 1.67
The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop Relat Res (1991) 1.66
Clinical experience with allograft implantation. The first ten years. Clin Orthop Relat Res (1983) 1.64
Management of patients with sarcoma of soft tissue in an extremity. Cancer (1973) 1.63
Giant synovial cysts of the calf in patients with rheumatoid arthritis. J Bone Joint Surg Am (1968) 1.62
Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer (1985) 1.62
Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg (1997) 1.61
Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol (1998) 1.59
Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res (2001) 1.59
Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am (1990) 1.57
Osteoid osteoma: percutaneous radio-frequency ablation. Radiology (1995) 1.57
Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys (1998) 1.56
The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study. J Bone Joint Surg Am (1997) 1.56
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol (2000) 1.54
Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology (1980) 1.53
The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest (1971) 1.52
Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg Am (1993) 1.52
The reaction of articular cartilage to injury and osteoarthritis (second of two parts). N Engl J Med (1974) 1.51
Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg (1999) 1.51
Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol (1993) 1.51
Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer (1987) 1.49
Early discharge after modified radical mastectomy. Am J Surg (1986) 1.47
The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities. Orthop Clin North Am (1987) 1.44
A complex bilateral polysyndactyly disease locus maps to chromosome 7q36. Nat Genet (1994) 1.44
Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg (1982) 1.44
Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol (1996) 1.43
Gorham's massive osteolysis: the role of radiation therapy and a review of the literature. Int J Radiat Oncol Biol Phys (1993) 1.43
The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg Am (1966) 1.43
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
The reaction of articular cartilage to injury and osteoarthritis (first of two parts). N Engl J Med (1974) 1.37
Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg Am (1990) 1.37
Carcinoid tumors of the appendix. Ann Surg (1993) 1.36
Collagen synthesis in normal and osteoarthritic human cartilage. J Clin Invest (1977) 1.35
Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys (2001) 1.34
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Osteochondromas of the distal aspect of the tibia or fibula. Natural history and treatment. J Bone Joint Surg Am (2000) 1.33
Postoperative spindle cell nodules of genitourinary tract resembling sarcomas. A report of eight cases. Am J Surg Pathol (1984) 1.31
Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg (1991) 1.30
Clinical and pathologic review of 48 cases of chordoma. Cancer (1985) 1.30
Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys (1984) 1.30
Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics (1995) 1.29
Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol (1988) 1.29
Frequent incidence of extrapulmonary sites of initial metastasis in patients with liposarcoma. Cancer (1995) 1.28
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol (2001) 1.26